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Long non-coding RNAs are frequently associated with broad modulation of gene expression and 22 
thus provide the cell with the ability to synchronize entire metabolic processes. We used 23 
transcriptomic approaches to investigate whether the most abundant human cytomegalovirus-24 
encoded lncRNA, RNA2.7, has this characteristic. By comparing cells infected with wild-type 25 
virus (WT) with cells infected with RNA2.7 deletion mutants, RNA2.7 was implicated in 26 
regulating a large number of cellular genes late in lytic infection. Pathway analysis indicated 27 
that >100 of these genes are associated with promoting cell movement, and the ten most 28 
highly regulated of these were validated in further experiments. Morphological analysis and live 29 
cell tracking of WT- and RNA2.7 mutant-infected cells indicated that RNA2.7 is involved in 30 
promoting the movement and detachment of infected cells late in infection, and plaque assays 31 
using sparse cell monolayers indicated that RNA2.7 is also involved in promoting cell-to-cell 32 
spread of virus. Consistent with the observation that upregulated mRNAs are relatively A+U-33 
rich, which is a trait associated with transcript instability, and that they are also enriched in 34 
motifs associated with mRNA instability, transcriptional inhibition experiments on WT- and 35 
RNA2.7 mutant-infected cells showed that four upregulated transcripts were longer-lived in the 36 
presence of RNA2.7. These findings demonstrate that RNA2.7 is required for promoting cell 37 
movement and viral spread late in infection and suggest that this may be due to general 38 














































In addition to messenger RNAs (mRNAs), the human genome encodes a large number of long 42 
non-coding RNAs (lncRNAs). Many lncRNAs that have been studied in detail are associated with 43 
broad modulation of gene expression and have important biological roles. Human 44 
cytomegalovirus, which is a large, clinically important DNA virus, specifies four lncRNAs, one of 45 
which (RNA2.7) is expressed at remarkably high levels during lytic infection. Our studies show 46 
that RNA2.7 is required for upregulating a large number of human genes, about 100 of which 47 
are associated with cell movement, and for promoting the movement of infected cells and the 48 
spread of virus from one cell to another. Further bioinformatic and experimental analyses 49 
indicated that RNA2.7 may exert these effects by stabilizing mRNAs that are relatively rich in A 50 
and U nucleotides. These findings increase our knowledge of how human cytomegalovirus 51 














































Long non-coding RNAs (lncRNAs) are untranslated transcripts of over 200 nucleotides (nt). 55 
More than 16,000 have been annotated in the human genome (Human GENCODE Release 56 
version 30), and many that have been studied in detail have been shown to be vital regulators 57 
of cellular processes. The functional importance of lncRNAs is also evident from the association 58 
of their dysregulation with over 300 human diseases (LncRNADisease database; (1)) and from 59 
loss-of-function experiments targeting lncRNAs in animal models that result in embryonic 60 
lethality or developmental defects (2). Cellular lncRNAs function in various ways, including 61 
guiding lncRNA-bound proteins to specific DNA sequences, acting as decoys for proteins or 62 
miRNAs, forming scaffolds for multi-protein complexes that would otherwise be 63 
thermodynamically unfavourable, altering RNA processing or translation directly by binding to 64 
DNA or RNA or indirectly by modulating the activity of regulatory proteins, and modulating 65 
signalling pathways (2-5). 66 
 67 
Herpesviruses also encode lncRNAs that regulate multiple processes during infection. Kaposi's 68 
sarcoma-associated herpesvirus polyadenylated nuclear (PAN) RNA is essential for late gene 69 
expression and viral propagation (6-8). Herpes simplex virus type 1  latency-associated 70 
transcript (LAT) influences various stages of latency (9). Human cytomegalovirus (HCMV; 71 
species Human betaherpesvirus 5) encodes four major lncRNAs (RNA1.2, RNA4.9, RNA5.0 and 72 
RNA2.7), in addition to at least 170 coding sequences (CDSs) for functional proteins (10-13). 73 












































κB activation (14). RNA4.9 has been reported to recruit the polycomb repression complex to 75 
suppress the activity of the HCMV major immediate-early promoter (MIEP) via chromatin 76 
remodelling (15), which could contribute to the establishment and maintenance of latent 77 
infection. RNA4.9 also facilitates lytic infection, forming an RNA-DNA hybrid (R-loop) with the 78 
origin of DNA replication (oriLyt) that may be involved in the initiation of viral DNA synthesis 79 
(16). 80 
 81 
RNA2.7 is approximately 2.5 kb in size (not including the polyadenylate tail) and is encoded by a 82 
gene that does not overlap known functional CDSs. It is relatively A+U-rich (55 %) and well 83 
conserved (78% identity in all sequenced strains), although both of these values are somewhat 84 
lower in the 300–400 nt at the 5’-end (data not shown). The gene is transcribed with early 85 
kinetics, thus being dependent on prior immediate-early gene expression. It is activated by 86 
immediate-early proteins 1 and 2 (IE1 and IE2 encoded by genes UL123 and UL122, 87 
respectively), and other viral gene products are also required for the extremely high levels of 88 
RNA2.7 expression during lytic infection (17). RNA2.7 has long been known to be the most 89 
abundant early transcript (18-21), and constitutes nearly half of all viral polyadenylated 90 
transcripts late in infection (22). Moreover, it is highly expressed in multiple cell types 91 
(fibroblasts, dendritic cells and macrophages) during lytic infection (22, 23), and there is 92 
evidence that it is also abundant during latency (24).  93 
 94 
RNA2.7 interacts with the GRIM-19 subunit of mitochondrial complex I (also known as 95 












































which is the first component in the mitochondrial electron transport chain, leading to the 97 
maintenance of ATP production and the protection of infected cells from apoptosis (25). 98 
Capitalizing on this activity, RNA2.7 protected endothelial cells from apoptosis in an in vitro 99 
model of ischemia/reperfusion injury (26) and has been administered successfully as a 100 
therapeutic treatment to prevent and rescue neuronal death in animal models of Parkinson’s 101 
disease (27). Given that the 796 nt sequence forming the 5’-terminal one-third of RNA2.7 102 
(termed the p137 region) was sufficient to protect cells from apoptosis (27), it is likely that the 103 
rest of this lncRNA performs additional roles. Observations consistent with this hypothesis have 104 
been reported, in that RNA2.7 is distributed throughout the nucleus and the cytoplasm, 105 
whereas mitochondrial complex I is located only in the mitochondrial membrane (16, 28), and 106 
in that protection of cells from apoptosis is unlikely in principle to require such high levels of 107 
RNA2.7. In the present study, we investigated the activities of RNA2.7 further by characterizing 108 
the properties of two RNA2.7 deletion mutants, with an emphasis on transcriptome profiling. 109 
RNA2.7 was required for regulating hundreds of cellular genes, and >100 of these genes were 110 
associated with promoting the movement of infected cells late in infection. The observation 111 
that upregulated transcripts tend to be A+U-rich and contain sequence motifs associated with 112 














































Analysis of growth kinetics 116 
The growth kinetics of three viruses generated from a bacterial artificial chromosome (BAC) of 117 
HCMV strain Merlin were examined: the parental virus (termed wild-type, WT) and two RNA2.7 118 
deletion mutants (ΔRNA2.7 and ΔTATA) (Fig. 1A). In ΔRNA2.7, the majority of the RNA2.7 coding 119 
sequence was deleted, from 50 bp upstream of the TATA box (TATAAA) to 50 bp upstream of 120 
the polyadenylation signal (AATAAA) that RNA2.7 shares with an upstream gene, RL5A. In 121 
ΔTATA, only the 6 nt of the TATA box were deleted. 122 
 123 
A phenotype has been reported for an RNA2.7 deletion mutant of HCMV strain Toledo (29), and 124 
the genome sequence of this mutant has been verified (13). The growth kinetics of this mutant 125 
were wild-type under standard culture conditions but inhibited under conditions of glucose 126 
deprivation. This phenotype was attributed to the increased susceptibility of mutant-infected 127 
cells to apoptosis and their decreased production of ATP (25). The ability of the Merlin RNA2.7 128 
mutants to grow in human foetal foreskin fibroblast (HFFF2) cells was examined under 129 
conditions of single-step and multi-step infection (Fig. 1B, C). Neither mutant showed a growth 130 
defect in cells under standard culture conditions, but both grew poorly under conditions of 131 
glucose deprivation, thus confirming with strain Merlin the earlier findings with strain Toledo 132 
(Fig. 1D). Both mutants also exhibited a growth defect in HFFF2 cells synchronized to the G0 133 













































Transcriptomic analysis 136 
Since many functions attributed to lncRNAs involve regulation of gene expression, differential 137 
expression of viral and cellular transcripts was examined in HFFF2 cells lytically infected with 138 
the RNA2.7 mutants in comparison to cells infected with WT. Illumina sequence data were 139 
obtained at three time-points post-infection (p.i.): 4 h p.i. for the effects of RNA2.7 140 
incorporated into input virions (15, 30) or expressed very early in infection, and 24 and 72 h p.i. 141 
for the effects of RNA2.7 expressed during the early and late stages of infection, respectively. 142 
 143 
Previous observations that RNA2.7 is expressed with early kinetics and accumulates as infection 144 
progresses (18, 19) were confirmed (Fig. 2A). The levels of all other viral transcripts were the 145 
same for each virus (Fig. 2B; Table S1A), indicating that the absence of RNA2.7 had no general 146 
effect on the proportion of viral RNA (excluding RNA2.7) expressed during the course of 147 
infection. These data dealt with the aggregate of viral RNAs and took no account of the 148 
behaviour of individual RNAs or whether they were sense or antisense (i.e. transcribed in the 149 
same direction as a gene or the opposite direction) (22, 31-33). To analyse individual genes, the 150 
numbers of reads originating from the sense and antisense strands of each of the 170 protein-151 
coding CDSs and four lncRNA-encoding regions were counted. Comparisons excluded RNA2.7, 152 
and differential regulation by RNA2.7 was registered when exhibited by both ΔRNA2.7 and 153 
ΔTATA above a defined probability threshold (q<0.05). 154 
 155 
No sense transcripts were differentially expressed by the mutants at 4 h p.i., and only one gene 156 












































from 22 genes were differentially expressed at 72 h p.i., with nine upregulated and 13 158 
downregulated (Table 1B). Differential expression by ΔRNA2.7 was moderate, ranging from 159 
upregulation by 1.66-fold to downregulation by 6.47-fold. RL5A, the 3’-untranslated region (3’-160 
UTR) of which overlaps RNA2.7, was the third most downregulated gene (3.89-fold). Despite 161 
the lack of the TATA box, expression of RNA2.7 at 72 h p.i. was observed in ΔTATA at 162 
approximately 10 % of the level in WT (Fig. 2A). The similarity of the transcription profiles of 163 
this region of the genome in WT and ΔTATA provided no evidence for an alternative promoter 164 
contributing significantly in the latter (Fig. 2C). No antisense transcripts were differentially 165 
regulated at 4 or 24 h p.i. At 72 h p.i., antisense transcripts to three genes in ΔRNA2.7-infected 166 
cells were upregulated by ≤1.45-fold, and transcripts antisense to 26 genes were 167 
downregulated by ≤2.25-fold (Fig. 3B; Table 1C; Table S1C). Only two loci were consistently 168 
dysregulated in both sense and antisense transcription (RL10 and UL142, both downregulated). 169 
There was no overall correlation between the differential expression of sense and antisense 170 
transcripts for all viral genes in mutant-infected cells at 72 h p.i. (Spearman’s correlation, 171 
p>0.05; Fig. 3C). 172 
 173 
No differentially expressed cellular RNAs were identified at 4 h and 24 h p.i.. At 72 h p.i., 1552 174 
genes were differentially expressed in ΔRNA2.7-infected cells, and 1200 were differentially 175 
expressed in ΔTATA-infected cells (Table S2). The differences in expression level were largely 176 
moderate: 99 % of the genes dysregulated in ΔRNA2.7-infected cells and ΔTATA-infected cells 177 
were differentially expressed by ≤4-fold. In both mutants, most dysregulated genes (74–76 %) 178 












































931 were common to both ΔRNA2.7 and ΔTATA, with 146 upregulated and 785 downregulated 180 
(Table S2). 181 
 182 
Role of cell movement genes 183 
The functions of the 931 cellular genes dysregulated by the RNA2.7 mutants were investigated 184 
by pathway analysis (Table 2). The most prominent category was cell movement, into which 185 
108 genes fell and which scored strongly by gene enrichment (p = 6.83e-10, Fisher’s exact test) 186 
and the concerted up- or downregulation of these genes (z = -5.187). Many genes in other high-187 
scoring categories, such as migration of cells and invasion of cells, were common to the cell 188 
movement category (final column in Table 2). Several of these cell movement-associated (CMA) 189 
genes were investigated further. 190 
 191 
Of the 108 CMA genes differentially expressed by the RNA2.7 mutants, 99 were downregulated 192 
and nine were upregulated (Table S3A). Ten genes were selected for further analysis that were 193 
highly expressed in WT-infected cells and dysregulated (all downregulated) by >1.8-fold in 194 
ΔRNA2.7-infected cells and by >1.6-fold in ΔTATA-infected cells (Table 3). These and all 195 
subsequent experiments were performed in HFFF2 cells that had been synchronised to the G0 196 
phase of the cell cycle by serum-starvation for 48 h prior to infection. Analysis of transcription 197 
of these genes by reverse transcription PCR (RT-PCR) showed that transcript levels were either 198 
maintained or upregulated by infection of cells with WT and markedly decreased during 199 
infection with ΔRNA2.7 or ΔTATA (Fig. 4A). Previously published transcriptomic data (34) 200 












































between 24 and 72 h p.i. (Fig. 5A). Two of these genes, encoding Tropomyosin 3 (TPM3) and 202 
Syntaxin 3 (STX3), were investigated further. Transcripts accumulated for each between 24 and 203 
120 h p.i. in WT-infected cells but remained at basal levels in cells infected with ΔRNA2.7 or 204 
ΔTATA (Fig. 5B), and immunoblotting analysis confirmed decreased protein levels of both 205 
proteins in cells infected with ΔRNA2.7 or ΔTATA (Fig. 4B). These experiments validated the 206 
downregulation of ten of the 108 regulated CMA genes at the transcriptional level and two at 207 
the protein level. Preliminary evidence that CMA protein levels follow transcript levels more 208 
generally was obtained by a single proteomic analysis of WT, ΔRNA2.7 and ΔTATA-infected cells 209 
at 72 h p.i., in which 73 of the 108 CMA genes were assessed (Table S4). Protein and transcript 210 
levels correlated strongly (Fig. 4C), although only the members of a subset of CMA proteins 211 
were significantly dysregulated by ΔRNA2.7 and ΔTATA (28/73 (38 %) and 19/73 (26 %), 212 
respectively (p<0.05)). 213 
 214 
The results described above implied that cells infected with the RNA2.7 mutants would exhibit 215 
lower motility than WT-infected cells at late times in infection. To investigate this, the two 216 
RNA2.7 mutations were introduced into the Merlin genome with the green fluorescent protein 217 
(GFP) CDS fused to a P2A self-cleaving peptide at the 3’-end of the UL36-coding region, in order 218 
to identify infected cells by live-cell microscopy. Human fibroblasts expressing the tetracyclin 219 
(Tet) repressor (HF-Tet) cells were infected with the parental virus (termed UL36-GFP-WT), 220 
UL36-GFP-ΔRNA2.7 or UL36-GFP-ΔTATA, and the speed of movement of infected cells was 221 
measured from 72 until 120 h p.i. The results showed that UL36-GFP-WT-infected cells moved 222 












































supporting the conclusion that RNA2.7 is involved in promoting the movement of infected cells. 224 
Microscopic analysis also revealed that, although cells infected with the RNA2.7 mutants readily 225 
developed cytopathic effects, the number of cells that became spherical was lower by 40 % in 226 
UL36-GFP-ΔRNA2.7-infected cells but not lower in UL36-GFP-ΔTATA-infected cells (Fig. 6B). 227 
Moreover, when infected spherical cells that had become detached from the monolayer were 228 
removed by replacing the medium, the number of remaining infected spherical cells was lower 229 
by 55 % in UL36-GFP-WT-infected cells but not lower in mutant-infected cells. These data 230 
suggest that, although low-level expression of RNA2.7 by UL36-GFP-ΔTATA (7–14 % of WT; Fig. 231 
2A; Fig. 5B) was sufficient to promote rounding of infected cells, high-level expression was 232 
required for increased detachment. Relevant to this phenotype, 15 of the 931 transcripts 233 
dysregulated by the RNA2.7 mutants are associated with focal adhesion formation (Table S3B). 234 
Overall, these results indicate that RNA2.7 may coordinate the regulation of CMA genes and 235 
thus enhance infected cell movement late in infection. 236 
 237 
During infection, motile infected cells are likely to make multiple contacts with uninfected cells, 238 
thus facilitating cell-to-cell transfer of virus. Therefore, we hypothesized that promotion of cell 239 
movement may be important for viral spread. To investigate this, HF-Tet cells were infected 240 
with UL36-GFP-WT, UL36-GFP-ΔRNA2.7 or UL36-GFP-ΔTATA. Late in infection, isolated infected 241 
cells were used to initiate infection in plaque assays on sparse or fully confluent monolayers in 242 
the presence of anti-HCMV blocking antibodies, and the number of GFP-positive cells per 243 
plaque was monitored. In sparse monolayers, there were 1.9-2.0-fold more infected cells in 244 












































either mutant, whereas there were no differences in confluent cell monolayers (Fig. 7). This 246 
again supports the conclusion that RNA2.7 may promote cell movement, resulting in increased 247 
cell-to-cell spread of infectious virus late in infection. 248 
 249 
Role of GRIM-19 250 
The analyses described above implicate RNA2.7 in coordinating the regulation (mostly up-251 
regulation) of multiple cellular genes, presumably in order to achieve specific functional goals, 252 
such as increasing infected cell movement and viral spread. It is not clear how this is 253 
accomplished, but a common mechanism may be involved. One possibility is through 254 
interactions with GRIM-19, to which RNA2.7 binds directly (25). To investigate this, three 255 
independent shRNA knockdown cell lines (KD1-KD3) against GRIM-19, and a control cell line, 256 
were generated from human fibroblasts immortalized by lentiviral transduction of a telomerase 257 
gene (HFT cells). The effectiveness of knockdown was confirmed at the transcript (Fig. 8A; left 4 258 
lanes) and protein levels (Fig. 8B), although that of KD1 was marginal. Expression of CMA genes 259 
during infection of these cell lines was also examined (Fig. 8A; right 12 lanes), and 260 
demonstrated that reduction in GRIM-19 level did not influence the level of transcription of any 261 
of the four CMA genes tested (TPM3, STX3, Dystroglycan 1 (DAG1) and Heme-binding protein 1 262 
(HEBP1)). These data indicate that GRIM-19 is unlikely to be involved in the regulation of CMA 263 













































Role of viral genes 266 
Attempts were made using a lentivirus-based system to determine whether expression of 267 
RNA2.7 in the absence of other HCMV genes is sufficient to upregulate CMA genes. However, 268 
even though RNA2.7 was under the control of the powerful HCMV MIEP lacking the IE2-specific 269 
repression signal that is commonly used in expression systems, levels of RNA2.7 expression 270 
were <4 % of those observed during HCMV infection. Efforts to rescue the RNA2.7 phenotype in 271 
the context of ΔRNA2.7 and ΔTATA infection were also unsuccessful, probably for the same 272 
reason. We also attempted using a recombinant adenovirus system at exceptionally high 273 
multiplicity of infection (MOI) to maximise RNA2.7 expression (also driven by the MIEP lacking 274 
the IE2-specific repression signal), but this resulted in the development of profound cytopathic 275 
effects. Infection with adenovirus under these conditions also prevented subsequent infection 276 
with HCMV, thus prohibiting complementation. These two widely used expression systems did 277 
not come anywhere near matching the power of the RNA2.7 promoter, and therefore it was 278 
not possible to assess the role of RNA2.7 in isolation or in complementing the RNA2.7 mutants. 279 
 280 
In an alternative approach to assessing whether regulation of CMA genes depends on the 281 
expression of other viral genes late in infection, phosphonoformic acid (PFA) was used to inhibit 282 
viral DNA synthesis and hence late gene expression. Cells infected with UL36-GFP-WT and 283 
treated with PFA moved 29 % more slowly than untreated cells at 48-96 h p.i. (Fig. 9A), whereas 284 
cells infected with UL36-GFP-ΔRNA2.7 and UL36-GFP-ΔTATA moved 38 % more slowly. These 285 
results suggest that expression of additional late viral genes is required for the regulation of 286 












































was half that in untreated cells at 72 h p.i., raising the perhaps unlikely possibility that this 288 
lower level was insufficient to promote RNA2.7-mediated regulation (Fig. 9B). 289 
 290 
Role of RNA2.7 subdomains 291 
Previously published work has shown that the 5’-terminal one-third of RNA2.7 (796 nt) is 292 
sufficient to bind to GRIM-19 and protect cells from apoptosis (27). To determine which parts of 293 
RNA2.7 are required for upregulation of CMA genes, mutants were generated that lacked either 294 
this subdomain or the remaining two-thirds of RNA2.7 (Δ5’ and Δ3’, respectively; Fig. 10A). The 295 
deletion in Δ5’ started 50 nt downstream of the transcription initiation site in order to limit 296 
promoter-associated effects on expression of the 3’ subdomain of RNA2.7, and the deletion in 297 
Δ3’ stopped 50 nt upstream of the polyadenylation signal in order to avoid affecting expression 298 
of the upstream gene RL5A, which shares this signal with RNA2.7. 299 
 300 
The impact of the deletions on CMA gene expression during infection of HFFF2 cells was 301 
assessed. The levels of all four transcripts examined (TPM3, STX3, DAG1 and HEBP1) were 302 
reduced in Δ5’-infected cells to levels similar to those in ΔRNA2.7-infected cells. The same 303 
observation was made for two of these genes (TPM3 and DAG1) in Δ3’-infected cells, whereas 304 
the other two genes (STX3 and HEBP1) were expressed at greater levels than in ΔRNA2.7-305 
infected cells (Fig. 10B). In addition, both UL36-GFP-Δ5’- and UL36-GFP-Δ3’-infected cells 306 
moved more slowly than UL36-GFP-WT-infected cells. The motility of UL36-GFP-Δ5’-infected 307 
cells and UL36-GFP-Δ3’-infected cells was 43–56 % lower than that of WT-infected cells, and 308 












































which motility was decreased by 42–43 % (Fig. 10C). In interpreting these results, it is important 310 
to note that the level of the residual part of RNA2.7 expressed in Δ3’-infected cells was similar 311 
to that of WT (74 %), whereas the level in Δ5’-infected cells was only 25 % and thus closer to 312 
that of ΔTATA (7 %) than WT (Fig. 10D, E). As a result, it may be concluded that the 5’-313 
subdomain cannot replace RNA2.7 in regulating CMA genes, but that the role of the 3’-314 
subdomain is unresolved. 315 
 316 
Role of mRNA stability 317 
The sequences of the 99 upregulated CMA mRNAs were analysed for characteristics distinct 318 
from those of other cellular mRNAs. The majority (64 mRNAs) have an A+U content of >49.6 %, 319 
which is greater than the average calculated for all cellular mRNAs (Fig. 11A). Since mRNA 320 
instability is associated with higher A+U content (35-41), we investigated whether CMA genes 321 
contain motifs associated with lower mRNA stability (35, 42, 43). These motifs comprise A+U-322 
rich elements (ARE motifs 1-2E in Table 4) that are based on a pentamer AUUUA core sequence 323 
and are known to promote mRNA decay when present in the 3’-UTR (43-45). Other A+U-rich 324 
motifs (MEG, H1-H3 and B1-B4) and some G+C-rich motifs are associated with lower stability 325 
when present in specific regions of an mRNA, and, conversely, the presence of some G+C-rich 326 
motifs (H-1, H-2, B-1 and B-2) correlates with higher mRNA stability in certain instances (35). 327 
 328 
The occurrence of instability motifs in the 99 upregulated CMA mRNAs was compared with that 329 
in an equal number of randomly selected mRNAs that are not in this category, with this process 330 












































selected mRNAs in the whole mRNA and the 3’-UTR, but lower in the 5’-untranslated region (5’-332 
UTR; Table 4; Table S5A). These mRNAs were also enriched in six A+U-rich motifs located in 333 
regions of the mRNA associated with faster decay, including the ARE motif in the 3’-UTR. These 334 
results suggest that upregulated CMA genes tend to encode less stable mRNAs, and that 335 
RNA2.7 may upregulate them by reducing their rate of decay. 336 
 337 
To investigate this further, transcription in infected HFFF2 cells was blocked from 72 h p.i. by 338 
using actinomycin D to inhibit RNA polymerase II, so that mRNA levels thereafter would be 339 
affected by decay but not synthesis. The transcript levels of CMA genes were normalized to that 340 
of GAPDH, which encodes a stable transcript having an A+U content of 41–45 % (depending on 341 
transcript variant) that has been used for this purpose in similar studies (46-48). For three of 342 
the CMA genes analysed (STX3, TPM3 and DAG1), the proportion of transcript that persisted in 343 
the presence of actinomycin D was consistently higher in cells infected with WT than in cells 344 
infected with ΔRNA2.7, ΔTATA, Δ5’ or Δ3’ (Fig. 12A, B, D). For HEBP1, the same trend was 345 
observed with ΔRNA2.7- and Δ5’-infected cells, but there was no significant difference between 346 
the persistence of transcripts in WT-infected cells and ΔTATA- or Δ3’-infected cells (Fig. 12C). 347 
These results indicate that RNA2.7 may upregulate CMA genes by inhibiting their decay. 348 
 349 
To investigate whether the modulation of CMA mRNA stability involving RNA2.7 extends to 350 
other cellular mRNAs, the features associated with mRNA stability were collated for the 931 351 
regulated genes (785 upregulated and 146 downregulated). As for the upregulated CMA 352 












































(average 52.8 %; Fig. 11B). Moreover, when the upregulated mRNAs were compared with an 354 
equal number of randomly selected mRNAs that are not in this category, with a total of 1000 355 
comparisons, they had a higher overall A+U content in all comparisons (Table 4; Table S5A). 356 
These mRNAs were also enriched in motifs associated with lower stability, even more so than 357 
the 99 upregulated CMA mRNAs. The general pattern was one of higher A+U content in the CDS 358 
and 3’-UTR and a significant enrichment of A+U-rich decay-associated motifs (Table 4; Table 359 
S5A). 360 
 361 
In contrast to the upregulated mRNAs, the majority (75.1 %) of the 146 downregulated mRNAs 362 
had an A+U content of <49.6 % (average 44.5 %; Fig. 11B), and the A+U content was 363 
significantly lower in all regions of the mRNA in 1000 comparisons with other cellular mRNAs 364 
(Table 4; Table S5A). Also, the downregulated mRNAs were not enriched in A+U-rich decay-365 
associated motifs, but instead were significantly reduced in six of them while having a higher 366 
than average occurrence of two stability-associated G+C-rich motifs (Table 4; Table S5A). In 367 
addition, two G+C-rich motifs associated with mRNA instability were present in the CDSs of 368 
downregulated mRNAs at above average frequency, although this may reflect the general G+C-369 
richness of these mRNAs. In summary, these findings indicate that nucleotide composition and 370 
the presence of motifs affecting RNA stability are prevailing features of the regulated cellular 371 
mRNAs, with upregulated transcripts typically comprising less stable A+U-rich mRNAs and 372 
downregulated transcripts comprising more stable G+C-rich mRNAs. In addition, although 373 
upregulated and downregulated mRNAs possess these opposing features, they share the 374 













































To investigate whether the modulation of mRNA stability applies to viral genes, the relationship 377 
between the A+U content of each viral CDS and the magnitude of its transcriptional 378 
dysregulation in RNA2.7 mutant-infected cells were assessed. As for cellular mRNAs, A+U-rich 379 
viral transcripts were associated with greater downregulation in the RNA2.7 mutants (Fig. 13A). 380 
This correlation was moderate for all viral genes (excluding RNA2.7) aggregated (Fig. 13A), and 381 
strong for the 22 differentially expressed genes (Fig. 13C). In contrast, the correlation was weak 382 
for all antisense transcripts aggregated (Fig. 13B) and negligible for the 29 differentially 383 
expressed antisense transcripts (Fig. 13D). Overall, antisense transcripts in WT-infected cells 384 














































Given the resources that HCMV devotes to producing RNA2.7, this lncRNA is likely to play 388 
important roles during infection. By comparing mutant-infected cells and WT-infected cells, 389 
RNA2.7 was shown to be required for broad modulation of gene expression by HCMV, with a 390 
large number of mRNAs being regulated late during lytic infection. The 931 transcripts 391 
identified were consistently dysregulated in three independent transcriptomic experiments by 392 
two different RNA2.7 deletion mutants, the more subtle of which (ΔTATA) differed from WT 393 
only by a 6 nt deletion, thus indicating that the phenotype was unlikely to be due to a genetic 394 
element other than the RNA2.7 gene. Pathway analysis revealed that 108 of the dysregulated 395 
cellular transcripts are associated with cell movement, and ten of the transcripts in this group 396 
were validated in further experiments. Immunoblotting analysis confirmed that protein 397 
expression of two CMA genes (TPM3 and STX3) by the RNA2.7 mutants followed the trend 398 
observed for the transcripts, and a preliminary proteomics analysis implied this may extend to 399 
other CMA genes. The lower proportion of significantly dysregulated CMA genes identified in 400 
the proteomics analysis may have been due to the different approaches taken to analyse 401 
expression and calculate significance, and perhaps also to the time taken for transcript levels to 402 
be represented in protein levels. Live cell tracking of RNA2.7 mutant-infected cells indicated the 403 
involvement of RNA2.7 in promoting cell movement late in infection, and morphological 404 
analysis experiments further indicated that RNA2.7 is involved in stimulating infected cell 405 
detachment. RNA2.7 was also observed to enhance cell-to-cell spread of virus in sparse cell 406 












































that RNA2.7 may boost intrahost viral dissemination in vivo, as cell-to-cell transmission (as 408 
opposed to cell-free transfer) is the main mode of HCMV spread (49). 409 
 410 
Enhancement of infected cell movement has been observed to play a key role in the spread of 411 
other viruses, such as vaccinia virus (50-53). Cell movement is likely to have complex roles, as 412 
HCMV infection has been described to increase the motility of monocytes and endothelial cells 413 
and the chemokine-mediated migration of smooth muscle cells (54-56), and to modulate the 414 
migration of dendritic cells (57), whereas other reports have suggested that HCMV hampers the 415 
movement of monocytes and macrophages (58, 59). The underlying mechanisms also appear to 416 
be wide-ranging, with modulation of motility being chemokine-dependent or -independent (54, 417 
57, 58, 60), mediated through various cellular or viral receptors (54-57), and involving 418 
stabilization or dramatic reorganization of the cytoskeleton (56, 58). Immobilization of infected 419 
immune cells may be advantageous in circumstances in which it impairs the host antiviral 420 
response. Other herpesviruses, such as Kaposi's sarcoma-associated herpesvirus and Epstein-421 
Barr virus, are also known to promote cell movement, but this has been observed largely in 422 
terms of promoting the invasiveness of infected, transformed cells during oncogenesis (61, 62). 423 
 424 
A preliminary analysis of growth kinetics showed that the RNA2.7 mutants had a defect when 425 
infecting cells that had been glucose-deprived or synchronized by serum starvation. The former 426 
property has been attributed previously to a direct interaction of the 5’ one-third of RNA2.7 427 
with GRIM-19 (25). It is possible that the effects of serum starvation have the same cause. 428 












































regulation are independent of GRIM-19. Analysis of the Δ5’ and Δ3’ mutants showed that the 430 
5’-subdomain, which is sufficient for binding GRIM-19 (27), cannot replace RNA2.7 in the  431 
regulation of CMA genes, but, because of low levels of transcription of the residual part of 432 
RNA2.7 in the Δ5’ mutant, the role of the 3’-subdomain was not determined. Overall, these 433 
results imply that a novel mechanism involving RNA2.7 is responsible for the regulation of 434 
cellular transcripts observed in our study. Also, deletion of either subdomain resulted in 435 
reduced levels of the residual part of the RNA2.7 transcript, suggesting that sequences within 436 
RNA2.7 may stabilize the lncRNA or regulate its transcription. A recent study demonstrated that 437 
a CNGGN pentaloop within the 5’-subdomain contributes to RNA2.7 stability (63). This 438 
pentaloop interacts with TENT4-ZCCHC14 complex, leading to TENT4-mediated addition of non-439 
A nucleotides to the polyadenylate tail of RNA2.7, thereby conferring protection from 440 
deadenylation by the CCR4-NOT (CNOT) complex. However, TENT4 depletion did not alter the 441 
level of RNA2.7, suggesting that RNA2.7 utilizes multiple redundant mechanisms to prevent its 442 
decay. Self-stabilisation is also a characteristic of other herpesvirus lncRNAs: herpes simplex 443 
virus type 1 LAT (64-68) and Kaposi’s sarcoma-associated herpesvirus PAN (69). 444 
 445 
An important caveat of our work is that experiments aimed at determining whether RNA2.7 is 446 
able to exert its effects alone and whether the phenotypes of the RNA2.7 mutants could be 447 
rescued by expressing RNA2.7 exogenously were compromised by the inability of the 448 
expression systems used to match the extremely high levels of RNA2.7 achieved during lytic 449 
infection. The foundational study on RNA2.7 function similarly relied on the phenotypes of an 450 












































isolation (25). In that and subsequent studies (26, 27), RNA2.7 was able to exert its anti-452 
apoptotic effect in isolation, whereas our experiments involving inhibition of viral DNA 453 
replication indicated that late viral gene products may be involved in the regulation of CMA 454 
genes. It is possible that the observed effects of RNA2.7 on ATP production, inhibition of 455 
apoptosis and cellular transcription are functionally interdependent (for example, regulation of 456 
energy production and differential control of gene expression might form a nexus operating on 457 
cell movement), but there are insufficient data to determine whether and to what extent this is 458 
the case. 459 
 460 
Cellular transcripts upregulated in the presence of RNA2.7, whether associated with cell 461 
movement or not, tend to be A+U-rich, which is a characteristic of unstable mRNAs. Moreover, 462 
they are enriched in the 3’-UTR in A+U-rich motifs that are targeted by mRNA decay pathways 463 
(70). The hypothesis arising from these correlations, that RNA2.7 is required for the 464 
upregulation of A+U-rich mRNAs, was supported by the finding that, when mRNA production 465 
was inhibited, upregulated transcripts persisted longer in WT-infected cells than RNA2.7 466 
mutant-infected cells. The means by which RNA2.7 achieves transcript stabilization is not 467 
known and will be the subject of future studies. Various hypotheses are possible, including that 468 
it interacts physically with A+U-rich mRNAs or that it sequesters components of the mRNA 469 
decay pathways, perhaps in association with additional viral functions. RNA2.7 is itself A+U-rich 470 
and contains five instability-associated motifs (one copy of motif 1 and three copies of motif H1 471 
in the 5’ region, and one copy of motif H1 in the 3’ region), raising the possibility that it 472 












































high level of RNA2.7 may be important for its function. Firstly, although RNA2.7 was readily 474 
detectable at 24 h p.i., the transcriptomic analysis did not identify any dysregulated cellular 475 
transcripts at that stage in cells infected by the RNA2.7 mutants. Additional RT-qPCR 476 
experiments confirmed this for two CMA genes (TPM3 and STX3). Secondly, ΔRNA2.7 was 477 
defective in the promotion of cell rounding, whereas ΔTATA was not, and this partial phenotype 478 
may be attributed to the low level of RNA2.7 expressed by the latter. It is also important to 479 
register that, although the majority of upregulated transcripts were above average in A+U 480 
content, 30.7 % were not. It remains to be determined whether these transcripts are also 481 
unstable, and whether RNA2.7 might regulate them indirectly via the moderation of A+U-rich 482 
transcripts or by another mechanism. 483 
 484 
In addition to regulating a large number of cellular mRNAs, RNA2.7 also regulated 22 viral 485 
transcripts. The genes encoding these transcripts include both early and late genes and are 486 
dispersed throughout the HCMV genome, although 12 occur in clusters of adjacent, similarly 487 
oriented genes (UL7, UL8, UL9 and UL10; US7, US8 and US9; UL55, UL56 and UL57; and UL144 488 
and UL145), possibly as a result of 3’-coterminality (the sharing of a 3’ end by a nested set of 489 
transcripts) (71, 72). Of the genes in this category with known functions, these appear to be 490 
primarily involved in immunomodulation, but this may be due to grouping of such genes in 3’-491 
coterminal families that have arisen by gene duplication. As for cellular transcripts, the 492 
susceptibility of viral transcripts to RNA2.7-associated regulation correlated with A+U-richness, 493 
suggesting that the effects of RNA2.7 are exerted on all transcripts in the cell. However, 494 












































did not correlate well with A+U-richness. This may have been due to a reduced sensitivity to the 496 
relatively low proportion of antisense transcripts or to the perturbation of a complex 497 
interdependence between sense and antisense transcription. 498 
 499 
Although RNA2.7 generally modulated expression of individual genes with moderate effect, a 500 
panoply of cellular and viral genes was targeted. By influencing multiple transcripts involved in 501 
the same functional pathway, alone or in concert with other viral functions, RNA2.7 exerted a 502 
strong cumulative effect, as demonstrated by the observations on cell motility. Indeed, many 503 
HCMV proteins are known to target specific cellular processes in a coordinated fashion, 504 
particularly those concerned with manipulating the host immune response (73, 74), and this 505 












































MATERIALS AND METHODS 507 
 508 
Cells and viruses 509 
Human embryonic kidney cells (293T cells; American Type Culture Collection, ATCC CRL-3216), 510 
HFFF2 cells (European Collection of Authenticated Cell Cultures, obtained from Sigma, 511 
86031405) and HF-Tet cells (75, 76) were maintained at 37 °C in Dulbecco’s modified Eagle’s 512 
medium supplemented with 10 % (v/v) fetal bovine serum (FBS), 100 U/ml penicillin and 100 513 
μg/ml streptomycin, and were passaged as monolayers every 3–4 days. HFT cells (77) were 514 
cultured as monolayers in the same manner with the addition of 50 μg/ml hygromycin B to 515 
maintain transduced cells. All cells were tested routinely for the absence of mycoplasma using 516 
the MycoAlert mycoplasma detection kit (Lonza). 517 
 518 
BACs containing the complete HCMV strain Merlin genome (Merlin-BAC; pAL1111; GenBank 519 
accession GU179001.1; (75)) or the Merlin genome with the GFP CDS fused to the 3’-end of the 520 
UL36 coding region (UL36-GFP-BAC; (34)) were used as parental viruses for constructing RNA2.7 521 
deletion mutants. Two genes (RL13 and UL128) are mutated in Merlin-BAC in order to avoid 522 
selecting mutants when virus is reconstituted by transfection into fibroblasts (78). In contrast, 523 
viruses reconstituted from UL36-GFP-BAC contain a repaired UL128 and have UL131A under the 524 
control of the Tet operator, so that they may be grown stably in repressing HF-Tet cells; the 525 
UL128, UL130 and UL131A proteins act as a complex involved in viral entry into non-fibroblast 526 
cells, and therefore viruses reconstituted from Merlin-BAC and UL36-GFP-BAC lack this 527 












































BAC recombineering technology (75, 78-80). Briefly, a KanR/RpsL/lacZ selectable cassette 529 
flanked by sequences directly adjacent to the region to be deleted was created. This cassette 530 
was transfected into Escherichia coli SW102 containing Merlin-BAC or UL36-GFP-BAC, allowing 531 
it to replace the sequence to be deleted by homologous recombination. Positive clones were 532 
selected using kanamycin. A second round of recombineering was then carried out, in which 533 
the cassette was removed using negative selection with streptomycin, resulting in markerless 534 
deletion of the target sequence. 535 
 536 
Parental and mutant viruses were reconstituted by transfecting Merlin-BAC-derived BACs into 537 
HFFF2 cells or UL36-GFP-BAC-derived BACs into HF-Tet cells using the basic nucleofector kit for 538 
primary mammalian fibroblasts (VPI-1002, Lonza) and electroporation program T-16. Working 539 
stocks of virus were prepared and titrated by plaque assay on the appropriate cell line. The 540 
complete genome sequence of each virus was determined by Illumina sequencing as described 541 
previously (76) and confirmed as being precisely as designed. The sequence data were also 542 
shown to contain no mycoplasma sequence contamination. 543 
 544 
The parental virus (termed wild-type, WT) and four RNA2.7 deletion mutants (ΔRNA2.7, ΔTATA, 545 
Δ5’ and Δ3’) were generated from Merlin-BAC and its derivative BACs. Similarly, the parental 546 
virus (termed UL36-GFP-WT) and the four RNA2.7 deletion mutants (UL36-GFP-ΔRNA2.7, UL36-547 
GFP-ΔTATA, UL36-GFP-Δ5’ and UL36-GFP-Δ3’) were generated from UL36-GFP-BAC and its 548 












































AY446894.2) were: ΔRNA2.7 and UL36-GFP-ΔRNA2.7, 2560-5050; ΔTATA and UL36-GFP-ΔTATA, 550 
4995-5000; Δ5’ and UL36-GFP-Δ5’, 4179-4923; and Δ3’ and UL36-GFP-Δ3’, 2560-4178. 551 
 552 
Analysis of growth kinetics 553 
For analysis under standard culture conditions, HFFF2 cells in 6-well plates were infected for 2 h 554 
with WT, ΔRNA2.7 or ΔTATA at the specified MOI (quantified in plaque-forming units/cell). The 555 
medium was then replaced with fresh medium after washing the cells once with fresh medium. 556 
Duplicate 450 µl aliquots of supernatant were harvested every 2-3 d and stored at -70 °C after 557 
pelleting suspended cells and debris by low-speed centrifugation. The pelleted material was 558 
added back into the originating well with 1 ml fresh medium. The stored aliquots of cell-free 559 
virus were thawed and titrated on HFFF2 cells. For analysis under conditions of glucose 560 
deprivation, HFFF2 cells were incubated in low-glucose (1 g/l) medium for 48 h prior to 561 
infection (MOI=5), and low-glucose medium was used throughout infection. For analysis under 562 
conditions of cell synchronization, HFFF2 cells were synchronized to the G0 phase of the cell 563 
cycle by incubation in medium lacking serum for 48 h prior to infection (MOI=5), after which the 564 
cells were incubated under standard culture conditions. 565 
 566 
Transcriptomic analysis 567 
HFFF2 cells in 12-well plates were incubated for 2 h with WT, ΔRNA2.7 or ΔTATA (MOI=5). The 568 
medium was then replaced with fresh medium after washing the cells once with fresh medium. 569 
Total cell RNA was harvested at 4, 24 or 72 h p.i. using Trizol (Invitrogen) and extracted using a 570 












































column DNase digestion step. Three independent experiments were performed. Sequencing 572 
libraries were prepared from each RNA sample using 500 ng RNA and a TruSeq stranded mRNA 573 
library preparation kit (Illumina, cat no. 20020594). The libraries were multiplexed and 574 
sequenced using a NextSeq500 with 1 x 75 nt high-output kits (Illumina). Each library generated 575 
a read dataset of about 40 million single-end reads with >91.2 % being high quality (>Q30). 576 
After demultiplexing, the reads were filtered for quality (>Q20) and trimmed of adapter 577 
sequences using Trim Galore v0.4.2.0 (https://github.com/FelixKrueger/TrimGalore). 578 
 579 
To analyse the overall viral transcriptome, Bowtie2 v2.3.5 (81) was used to align the reads to 580 
the Merlin genome sequence (GenBank accession AY446894.2) lacking the RNA2.7 sequence 581 
(2489-4969 nt). These results permitted the proportion of viral reads (excluding RNA2.7) to be 582 
determined in comparison with the total number of reads. The trimmed reads were also 583 
aligned to the complete Merlin genome sequence, and the difference between the number of 584 
aligned reads and that in the alignment lacking the RNA2.7 sequence was taken to be the 585 
number of RNA2.7 reads. To analyse the transcript levels of individual viral genes, the reads 586 
were aligned to the sequences of each of the 170 Merlin CDSs and the four major lncRNA-587 
encoding regions (22) using Bowtie2. The reads in each alignment were sorted into those 588 
originating from sense and antisense transcripts, using an in-house script (SamSplit; (82)), and 589 
realigned with the relevant sequence. The alignments were visualized using Tablet v1.14.11.07 590 
(83). Reads per kilobase per million mapped reads (RPKM) values were determined as described 591 
previously (84), thus normalizing the number of mapped reads to CDS length. RNA2.7 reads 592 












































WT and RNA2.7 mutant data. Significant changes in viral gene expression (calculated as log2fold 594 
change) were determined from the three independent experiments using the R software Limma 595 
(q<0.05) (85). 596 
 597 
To analyse the cellular transcriptome, dataset quality was confirmed using FastQC 598 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc). The reads were aligned to the 599 
human genome sequence (hg19; https://genome.ucsc.edu) using Tophat2 v2.1.1 (86). Genes in 600 
RNA2.7 mutant-infected cells that were differentially expressed compared to WT-infected cells 601 
were identified using Cufflinks/Cuffdiff v2.2.1 (http://cole-trapnell-602 
lab.github.io/cufflinks/install/) (87). The false discovery rate of differentially expressed 603 
transcripts was determined using the Benjamini-Hochberg method, which produced a q value 604 
for each gene that was considered statistically significant at <0.05. Pathway analysis was 605 
performed using Ingenuity Pathway Analysis software (IPA, Qiagen, 2016 release). 606 
 607 
Proteomic analysis 608 
Confluent HFFF2 cells in 175 cm2 flasks were infected for 2 h with WT, ΔRNA2.7 or ΔTATA 609 
(MOI=5). The medium was then replaced with fresh medium after washing the cells once with 610 
fresh medium. At 72 h p.i., the cells were washed twice with phosphate-buffered saline (PBS), 611 
after which lysis buffer (6 M guanidine and 50 mM HEPES pH 7) was added, and the lysed cells 612 
were harvested by scraping. The samples were sonicated (30 s on and 30 s off for 10 cycles), and 613 
the debris was pelleted by low-speed centrifugation. The cell lysate samples were processed for 614 












































data were analysed as described previously (34, 88). A single experiment was conducted, in 616 
which 7961 infected cell proteins were identified, including 115 specified by HCMV. Proteins 617 
that were differentially expressed in RNA2.7 mutant-infected cells compared to WT-infected 618 
cells were identified by calculating Benjamini-Hochberg corrected Significance B values (89), 619 
and those with p<0.05 were considered to be significant. 620 
 621 
Transcript quantification by PCR 622 
Confluent HFFF2 or HF-Tet cells in 12-well plates were serum-starved by incubation in the 623 
absence of FBS for 48 h prior to infection, in order to synchronize the cell cycle to the G0 phase. 624 
The cells were then infected for 2 h with WT, ΔRNA2.7, ΔTATA, Δ5’ or Δ3’, or with UL36-GFP-WT, 625 
UL36-GFP-ΔRNA2.7, UL36-GFP-ΔTATA, UL36-GFP-Δ5’ or UL36-GFP-Δ3’ (MOI=5). The medium 626 
was then replaced with fresh medium after washing the cells once with fresh medium. Where 627 
appropriate, infected cells were treated with 300 µg/ml PFA (a viral DNA polymerase inhibitor) 628 
immediately following the 2 h adsorption period. The infected cells were harvested at 72 h p.i. 629 
using Trizol, and total cellular RNA was isolated using Direct-zol, including the on-column DNase 630 
digestion step. 631 
 632 
For RT-PCR, reverse transcription was performed using GoScript (Promega) with oligo d(T) as 633 
primer, and the resulting cDNA was used as the template for PCR reactions to amplify specific 634 
transcripts along with the GAPDH and G6PD transcripts, which were used to confirm equal 635 
loading. Either the Advantage 2 system (Clontech) or the Phusion system (New England Biolabs) 636 












































step RT-qPCR system QuantiTect Virus + ROX Vial kit (Qiagen) was used to quantify the levels of 638 
the TPM3, STX3, RNA2.7 and GAPDH transcripts (primers and probes are listed in Table S6), and 639 
data were collected using the Applied Biosystems™ 7500 Real-Time PCR system (Thermo 640 
Fisher). Relative transcript concentrations were determined by comparison to a standard curve 641 
and normalized to the level of GAPDH transcript. 642 
 643 
Immunoblotting analysis 644 
Confluent HFFF2 cells in 12-well plates were serum-starved for 48 h and infected for 2 h with 645 
WT, ΔRNA2.7 or ΔTATA (MOI=5). The medium was then replaced with fresh medium after 646 
washing the cells once with fresh medium. At 72 h p.i., cell lysates were harvested using 647 
Laemmli sample buffer (90). The proteins were resolved on 4-20 % (w/v) precast TGX 648 
polyacrylamide gels (Bio-Rad) using the MiniPROTEAN Tetra system (Bio-Rad), and transferred 649 
to polyvinylidene difluoride membranes (Thermo Scientific). The membranes were blocked with 650 
PBS containing 5 % (v/v) FBS on a roller machine for 1 h, and incubated in PBS containing 5 % 651 
(v/v) FBS, 0.1 % (v/v) Tween 20 and primary antibodies targeting TPM3 (0.4 µg/ml, HPA009066, 652 
Human Protein Atlas), STX3 (0.4 µg/ml, HPA002191, Human Protein Atlas), GRIM-19 (0.4 µg/ml, 653 
HPA041213, Human Protein Atlas) or Actin (1:4,000 dilution, A1978, clone AC-15, Sigma). The 654 
target proteins were visualised by incubating with fluorophore-conjugated secondary 655 
antibodies against rabbit (1:10,000, 35568, Thermo Fisher) or mouse (1:10,000, SA5-35521, 656 
Invitrogen) immunoglobulin in PBS containing 5 % (v/v) FBS and 0.1 % (v/v) Tween 20. The 657 













































Live cell fluorescence imaging analysis 660 
Confluent HF-Tet cells in 12-well plates were serum-starved for 48 h prior to infection for 2 h 661 
with UL36-GFP-WT, UL36-GFP-ΔRNA2.7, UL36-GFP-ΔTATA, UL36-GFP-Δ5’ or UL36-GFP-Δ3’ 662 
(MOI=5). The medium was then replaced with fresh medium after washing the cells once with 663 
fresh medium. Where appropriate, infected cells were treated with 300 µg/ml PFA immediately 664 
following the 2 h viral adsorption period. The medium was then replaced with fresh medium 665 
immediately before carrying out automated time-lapse, multi-position, dual-channel 666 
microscopy at 48-120 h p.i. at 20x magnification using the Cell Observer live cell imaging system 667 
(Zeiss) fitted with the CO2 module, Temp module S and Incubator XLmulti S1. Images of five 668 
random fields of view per well with duplicate wells per condition were obtained every 10 min 669 
using both the brightfield and GFP channels. GFP expression was confirmed in all cells, and was 670 
tracked using the Fiji plug-in TrackMate v3.4.2 (91). GFP-expressing cells were identified by the 671 
LoG detector; the estimated cell diameter was set at 0.002 cm; only spots of quality >0.3 were 672 
accepted; the Linear Assignment Problem (LAP) algorithm was used to create the cell 673 
movement tracks, for which the maximum frame-to-frame linking distance was 0.002 cm, the 674 
maximum track distance for gap-closing was 0.003 cm, the maximum gap was 2 frames, and the 675 
maximum distance permitted for track segment splitting was 0.002 cm; and only tracks with at 676 
least 15 successful detections of the same cells and a quality standard deviation of >0.1 were 677 














































Analysis of infected cells in individual plaques 681 
Confluent HF-Tet cells in 12-well plates were serum-starved for 48 h prior to infection for 2 h 682 
with UL36-GFP-WT, UL36-GFP-ΔRNA2.7 or UL36-GFP-ΔTATA (MOI=5). The medium was then 683 
replaced with fresh medium after washing the cells once with fresh medium. The infected cells 684 
were tryspinised at 72-96 h p.i. and resuspended in medium. Dispersal into isolated cells was 685 
confirmed microscopically, and cell density was determined twice using a hemocytometer. 686 
About 60 cells were used to seed plaques in partially (25 %) or fully confluent HF-Tet cells in 6-687 
well plates in the presence of 50 μg/ml Cytotect anti-HCMV antibody (Biotest) (92). The number 688 
of infected (GFP-expressing) cells in each of the plaques in duplicate wells was counted after 48 689 
h had elapsed, resulting in the assessment of 70–100 plaques per virus in each experiment. 690 
 691 
Generation of GRIM-19 knockdown cell lines  692 
Derivatives of the TRC lentiviral cloning vector (93) encoding shRNAs against three different 693 
regions of the GRIM-19 gene (TRCN000006492, TRCN0000064929 and TRCN0000236379; 694 
Sigma) or a non-targeting control shRNA (SHC002; Sigma) were transfected using Lipofectamine 695 
3000 (Sigma) into 293T cells with the Δ8.9 and pVSV-g plasmids to produce infectious 696 
lentiviruses (94). The lentiviruses were used to transduce HFT cells, and successfully transduced 697 














































Analysis of RNA stability motifs and nucleotide composition 701 
Enrichment of RNA stability motifs in query datasets of human mRNAs was tested using a 702 
randomization approach. The query data set was either the 146 downregulated genes, the 785 703 
upregulated genes, or the subset of 99 upregulated CMA genes. Human genome annotation 704 
hg19 was used. No genes were excluded from the CMA gene query dataset, but five 705 
downregulated transcripts and eight upregulated transcripts (Table S5B) were excluded from 706 
the total query dataset because the genes lacked protein identities in the human genome 707 
database. Nonetheless, nearly all regulated cellular genes (98.6 %) were included in the 708 
analysis. 709 
 710 
The total number of motifs in all sequences was counted in each query dataset using a sliding 711 
window of a size equal to that of the motif, shifted in 1 nt increments. For genes with multiple 712 
transcript variants, the longest variant was used. The mean number of each motif per sequence 713 
in a query dataset was calculated for the entire mRNA and also for separate regions: the 5’-714 
UTR, the 3’-UTR and the CDS. This analysis was repeated with 1000 datasets containing a 715 
number of sequences equal to that in the query dataset, each randomly sampled from the 716 
human genome database (GRCh38.p12; https://www.ensembl.org/info/data/ftp/index.html). 717 
The mean number of each motif per sequence in each randomly sampled dataset was 718 
compared with that from the query dataset. The difference was considered to be significant if 719 
this number was higher or lower in >950/1000 comparisons (i.e. p<0.05). All A+U analyses were 720 














































Data and tool availability 724 
Transcriptomic sequence read datasets were deposited in the NCBI Sequence Read Archive 725 
under the following accession numbers: WT 4 h, SRX8009962, SRX8009951, SRX8009950; 726 
ΔRNA2.7 4 h, SRR12424745, SRR12424744, SRR12424753; ΔTATA 4 h, SRR12424752, 727 
SRR12424751, SRR12424750; WT 24 h, SRX8009953, SRX8009952, SRX8009976; ΔRNA2.7 24 h, 728 
SRR12424747, SRR12424749, SRR12424748; ΔTATA 24 h, SRR12424746, SRR12424743, 729 
SRR12424742; WT 72 h, SRX8009963, SRX8009961, SRX8009960; ΔRNA2.7 72 h, SRR12424759, 730 
SRR12424757, SRR12424758; and ΔTATA 72 h, SRR12424756, SRR12424755, SRR12424754. 731 
Proteomic datasets were deposited in the ProteomeXchange with identifier PXD022277. The 732 
Python script for analysing stability motif enrichment is available in Github 733 
(https://github.com/salvocamiolo/stabilityMotifs.git). 734 
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Table 1. Effects of RNA2.7 on viral transcription. 1023 
HFFF2 cells were infected at MOI=5 with WT, ΔRNA2.7 or ΔTATA. Strand-specific sequence 1024 
reads were generated from polyadenylated RNA isolated at 24 or 72 h p.i., sorted into reads 1025 
originating from the sense and antisense transcripts for each CDS, and counted. The results are 1026 
shown as log2fold change (log2FC) values. Significantly dysregulated transcripts (q<0.05) are 1027 
listed for (A and B) sense and (C) antisense transcripts. The results of three independent 1028 
experiments are shown. 1029 
 1030 
A 1031 
24 h p. i. 
ΔRNA2.7 vs WT ΔTATA vs WT 
ORF log2FC q ID log2FC q 













































72 h p. i.  
WT vs ΔRNA2.7 WT vs ΔTATA 
ORF log2FC q ORF log2FC q 
US9 0.73 0.0160 US9 0.88 0.0175 
US8 0.73 0.0153 US8 0.85 0.0183 
UL57 0.69 0.0073 UL57 0.55 0.0164 
UL37 0.63 0.0424 UL37 0.71 0.0338 
UL56 0.57 0.0176 UL56 0.43 0.0459 
UL130 0.46 0.0274 UL130 0.47 0.0439 
UL72 0.45 0.0208 UL72 0.45 0.0299 
UL20 0.45 0.0220 UL20 0.52 0.0299 
UL55 0.45 0.0160 UL55 0.32 0.0420 
US26 -0.42 0.0153 US26 -0.30 0.0447 
US7 -0.55 0.0208 US7 -0.40 0.0439 
UL10 -0.66 0.0208 UL10 -0.56 0.0408 
UL144 -0.68 0.0094 UL144 -0.64 0.0139 
UL145 -0.74 0.0073 UL145 -0.40 0.0420 
RL10 -0.94 0.0056 RL10 -0.76 0.0089 
UL8 -1.19 0.0073 UL8 -1.20 0.0057 
UL9 -1.36 0.0073 UL9 -1.33 0.0052 
UL7 -1.37 0.0040 UL7 -1.26 0.0052 
UL1 -1.43 0.0028 UL1 -1.15 0.0052 
RL5A -1.96 0.0004 RL5A -1.22 0.0052 
UL142 -2.46 0.0220 UL142 -2.15 0.0408 













































72 h p. i.  
ΔRNA2.7 vs WT ΔTATA vs WT 
ORF log2FC q ORF log2FC q 
UL124 0.54 0.0070 UL124 0.56 0.0172 
UL73 0.41 0.0144 UL73 0.43 0.0172 
UL32 0.36 0.0275 UL32 0.37 0.0237 
RL10 -0.34 0.0459 RL10 -0.39 0.0470 
RL12 -0.41 0.0452 RL12 -0.53 0.0238 
UL23 -0.41 0.0254 UL23 -0.56 0.0130 
UL91 -0.43 0.0305 UL91 -0.54 0.0463 
US13 -0.43 0.0144 US13 -0.54 0.0115 
US28 -0.44 0.0396 US28 -0.47 0.0402 
UL16 -0.50 0.0111 UL16 -0.43 0.0238 
UL72 -0.53 0.0081 UL72 -0.38 0.0320 
US10 -0.53 0.0075 US10 -0.54 0.0149 
US12 -0.57 0.0098 US12 -0.76 0.0046 
UL6 -0.59 0.0029 UL6 -0.42 0.0226 
US9 -0.63 0.0029 US9 -0.53 0.0091 
UL71 -0.63 0.0469 UL71 -0.81 0.0172 
US18 -0.66 0.0028 US18 -0.67 0.0043 
US7 -0.67 0.0037 US7 -0.58 0.0098 
UL142 -0.69 0.0111 UL142 -0.55 0.0238 
US11 -0.72 0.0134 US11 -0.89 0.0091 
US8 -0.76 0.0012 US8 -0.77 0.0043 
UL5 -0.76 0.0028 UL5 -0.70 0.0046 
US6 -0.78 0.0028 US6 -0.70 0.0043 
RL13 -0.79 0.0029 RL13 -0.73 0.0091 
RL9A -0.82 0.0134 RL9A -0.79 0.0226 
UL20 -0.83 0.0037 UL20 -0.62 0.0172 
US27 -0.85 0.0012 US27 -0.76 0.0043 
US3 -1.03 0.0029 US3 -0.58 0.0172 
UL2 -1.170 0.0009 UL2 -0.866 0.0046 












































Table 2. Functional categorization of transcripts differentially expressed by RNA2.7 mutants. 1035 
Pathway analysis of the 931 regulated cellular genes. Significance is indicated by p-value, and 1036 
increased or decreased activity of the implicated biological function by z-score. 1037 
Function or effect p 
Predicted activation state 
in RNA2.7 mutants z No. of genes 
No. of genes in  
cell movement 
category 
Cell movement 6.83E-10 Decreased -5.187 108 108 
Migration of cells 3.66E-08 Decreased -4.688 95 95 
Invasion of cells 3.28E-05 Decreased -4.064 53 30 
Migration of endothelial cells 1.21E-04 Decreased -3.857 27 27 
Invasion of tumor cell lines 4.48E-04 Decreased -3.795 41 23 
Cell movement of endothelial cells 7.57E-05 Decreased -3.739 29 29 
Homing of cells 1.20E-03 Decreased -3.729 30 30 
Development of vasculature 6.16E-03 Decreased -3.705 38 0 
Angiogenesis 9.11E-03 Decreased -3.705 37 0 
Chemotaxis 1.93E-03 Decreased -3.607 29 29 
Chemotaxis of cells 3.47E-03 Decreased -3.607 27 27 
Formation of cellular protrusions 1.07E-04 Decreased -3.498 33 14 
Cell movement of leukocytes 4.17E-03 Decreased -3.430 29 29 
Organization of cytoskeleton 1.52E-04 Decreased -3.321 56 27 
Cellular homeostasis 6.61E-05 Decreased -3.295 63 0 
Microtubule dynamics 1.79E-04 Decreased -3.130 42 18 
Proliferation of blood cells 6.18E-03 Decreased -2.988 28 0 
Invasion of carcinoma cell lines 1.23E-02 Decreased -2.909 15 0 













































Table 3. Effects of RNA2.7 on expression of regulated CMA genes. 1039 
Transcriptomic analysis at 72 h p.i. of HFFF2 cells infected at MOI=5 with WT, ΔRNA2.7 1040 
(denoted Δ2.7) or ΔTATA. Transcript levels of ten CMA genes that are highly expressed in WT-1041 
infected cells and downregulated in RNA2.7 mutant-infected cells are shown as RPKM and  1042 





Transcript level (RPKM) Fold change vs WT (log2FC) 
Gene WT Δ2.7 ΔTATA Δ2.7 q ΔTATA q 
TPM3 551.2 178.6 225.2 -1.626 0.001 -1.291 0.001 
RTN4 338 171.6 209.8 -0.978 0.001 -0.688 0.001 
LASP1 174.3 58.3 69.4 -1.580 0.001 -1.329 0.001 
STX3 79.6 24.4 27.8 -0.878 0.001 -0.692 0.001 
S1PR1 70.5 17.2 20.6 -1.706 0.001 -1.518 0.001 
HEBP1 61.6 26.8 31.5 -2.035 0.001 -1.775 0.001 
DAG1 55.8 26.2 30 -1.201 0.001 -0.968 0.001 
CXXC5 44.3 15.7 19.4 -1.091 0.001 -0.895 0.001 
PDCL 43.6 19.1 19.8 -1.497 0.001 -1.191 0.001 
STX6 29 13.7 14.3 -1.191 0.001 -1.139 0.001 












































Table 4. Effects of nucleotide composition and stability-associated motifs on mRNAs 1045 
regulated in association with RNA2.7. 1046 
Occurrence per regulated mRNA of each sequence motif associated with stability or instability 1047 
in comparison with an equal number of other human transcripts in 1000 randomizations. 1048 
Higher occurrences in regulated mRNAs in >950 comparisons (i.e. p<0.05) were considered to 1049 
be enriched, and lower occurrences in >950 comparisons were considered to be reduced. 1050 
Motifs enriched in mRNA regions associated with decreased or increased mRNA stability are in 1051 
bold or italics, respectively. Results are shown for the 99 upregulated CMA mRNAs, all 785 1052 
upregulated mRNAs and all 146 downregulated mRNAs. [AU], A or U; (n) following [AU] 1053 
indicates the number of such nucleotides when >1. 1054 
 1055 
    Upregulated CMA genes   Upregulated genes    Downregulated genes   
Feature or motif Motif sequence 5' UTR CDS 3' UTR mRNA 5' UTR CDS 3' UTR mRNA 5' UTR CDS 3' UTR mRNA 
%A+U - Reduced - - Enriched Reduced Enriched Enriched Enriched Reduced Reduced Reduced Reduced 
1 [AU]AUUUA[AU] - - Enriched Enriched - Enriched Enriched Enriched - Reduced Reduced Reduced 
2A AUUUAUUUAUUUAUUUAUUUA - - - - - - - - - - - - 
2B AUUUAUUUAUUUAUUUA - - - - - - - - - - - - 
2C [AU]AUUUAUUUAUUUA[AU] - - - - - - - - Enriched - - - 
2D [AU](2)AUUUAUUUA[AU](2) - - - - - - Enriched Enriched Enriched - - - 
2E [AU](4)AUUUA[AU](4) - - - - - - - - - - - - 
MEG UUAUUUAUU - - - - - - Enriched Enriched - - - - 
MEGSHORT UAUUUAU - - Enriched Enriched - Enriched Enriched Enriched - Reduced - - 
H1 UUUUUUU Enriched - Enriched Enriched - - Enriched Enriched - - Reduced Reduced 
H2 UUUUUAAA - - Enriched Enriched - - Enriched Enriched - - Reduced Reduced 
H3 UUGUAAAUA - - Enriched Enriched - - Enriched Enriched - - - - 
B1 UUUUAAAU - - Enriched Enriched - - Enriched Enriched - - Reduced Reduced 
B2 UUUUAAUUU Enriched - - - - - Enriched Enriched - - - - 
B3 AAAUAUUUU - - - - - - Enriched Enriched - - Reduced Reduced 
B4 AAUAUUUUU - - - - - - Enriched Enriched - - - - 
H-1 CCGCCUC Enriched - - - Enriched - - Enriched - Enriched - - 
H-2 CCAGCCUC - - - - - - - - - Enriched - - 
B-1 GGGCCUGG - - - - - Reduced - - Enriched Enriched Enriched Enriched 
B-2 CCCAGCCCC - - - - - - - - - - Enriched Enriched 












































Fig. 1. Effects of RNA2.7 on viral growth kinetics. 1057 
(A) Diagram depicting the regions deleted in the RNA2.7 mutants (ΔRNA2.7 and ΔTATA) in 1058 
comparison with WT. The RNA2.7-coding region is indicated by a blue arrow, the TATA box by a 1059 
red line, the polyadenylation (polyA) signal by a yellow line and deleted regions by grey-shaded 1060 
rectangles. Numbers indicate the distance (nt) from the transcription initiation site (at 1 nt). In 1061 
the HCMV genome, the RNA2.7 gene is oriented leftward near the left end (22). For analysis 1062 
under standard culture conditions, HFFF2 cells were infected at (B) MOI=1 or (C) MOI=0.001 1063 
with WT, ΔRNA2.7 or ΔTATA, and cell-released viral titers were determined. For analysis under 1064 
conditions of (D) glucose deprivation or (E) cell synchronization, HFFF2 cells were infected with 1065 
WT, ΔRNA2.7 or ΔTATA at MOI=5. Each result represents one of three independent 1066 
experiments, with each error bar indicating the standard deviation of technical replicates. PFU, 1067 
plaque-forming units. 1068 
 1069 
Fig. 2. Effects of RNA2.7 on viral transcription. 1070 
HFFF2 cells were infected at MOI=5 with WT, ΔRNA2.7 or ΔTATA. Sequence reads generated 1071 
from polyadenylated RNA isolated at 4, 24 or 72 h p.i. were aligned to the WT and ΔRNA2.7 1072 
genome sequences and counted. Each error bar indicates the standard deviation of three 1073 
independent experiments. Data are shown for reads from (A) RNA2.7 and (B) all other viral 1074 
transcripts, and are expressed as percentages of all viral and host reads (% total reads). N.S., 1075 
not significant. (C) Alignment of sense reads from WT- and ΔTATA-infected cells at 72 h p.i. to 1076 












































indicate higher coverage. The two plots are shown on different scales: ΔTATA expressed 1078 
approximately 10 % of the level of RNA2.7 expressed by WT (Fig. 2A). 1079 
 1080 
Fig. 3. Effects of RNA2.7 on viral sense and antisense transcription. 1081 
HFFF2 cells were infected at MOI=5 with WT, ΔRNA2.7 or ΔTATA. Sequence reads generated 1082 
from polyadenylated RNA isolated at 4, 24 or 72 h p.i. were aligned to the WT and ΔRNA2.7 1083 
genome sequences, sorted into those originating from sense and antisense transcripts from 1084 
each CDS, and counted. (A) Sense and (B) antisense expression of viral transcripts by the 1085 
mutants were compared to those of WT and are shown as log2fold change (log2FC) values. 1086 
Significantly dysregulated transcripts (q<0.05) are marked by orange dots. (C) Lack of 1087 
correlation between sense and antisense log2FC values in the RNA2.7 mutants. The data were 1088 
generated from three independent experiments. 1089 
 1090 
Fig. 4. Effects of RNA2.7 on expression of regulated CMA genes. 1091 
(A) Synchronized HFFF2 cells were infected at MOI=5 with WT, ΔRNA2.7 (denoted Δ2.7) or 1092 
ΔTATA. At 72 h p.i., the transcript levels of ten cell movement-associated (CMA) genes that 1093 
were highly expressed in WT-infected cells and downregulated in mutant-infected cells in the 1094 
transcriptomic analysis were confirmed by RT-PCR, with GAPDH and G6PD serving as loading 1095 
controls. One representative result of three independent experiments is shown. (B) Protein 1096 
levels for two of these genes examined by immunoblotting analysis. Band density was 1097 
normalized to the Actin loading control, and expression levels relative to WT-infected cells for 1098 












































CMA genes that were registered in both the transcriptomic and proteomic analyses. These 1100 
were calculated as log2fold change (log2FC) values relative to WT. R and p define the strength 1101 
and significance of the correlation, respectively. M, mock-infected. Error bars denote standard 1102 
deviation values. 1103 
 1104 
Fig. 5. Effects of HCMV infection on transcription of CMA genes.  1105 
HFFF2 cells were infected at MOI=5 with WT, ΔRNA2.7 or ΔTATA. (A) Data for ten highly 1106 
expressed CMA genes that were upregulated in the presence of RNA2.7 were extracted from 1107 
Table S1 of a published report (36). Immortalised fibroblasts (HFFF-TERT cells) were infected at 1108 
MOI=5 or 10 with HCMV strain Merlin in three biological replicates, and transcript abundance 1109 
was determined by sequencing RNA samples harvested at 0 (mock-infected), 24 or 72 h p.i. 1110 
RPKM values were normalized for each gene to the highest level observed during the time 1111 
course. (B) Data for RNA2.7, TPM3 and STX3 transcripts determined by RT-qPCR and normalized 1112 
to that of the GAPDH transcript. Each result represents one of three independent experiments, 1113 
with error bars indicating the standard deviation of technical replicates. 1114 
 1115 
Fig. 6. Effects of RNA2.7 on movement and rounding of cells. 1116 
Synchronized HF-Tet cells were infected at MOI=5 with UL36-GFP-WT, UL36-GFP-ΔRNA2.7 1117 
(denoted ΔRNA2.7) or UL36-GFP-ΔTATA (denoted ΔTATA). (A) Fluorescent live cell microscopy 1118 
and cell tracking performed at 72–120 h p.i., with images taken every 10 min. The data 1119 
represent three independent experiments, each involving duplicate wells and five independent 1120 












































Infected cell roundness, as defined by an aspect (breath versus width) ratio of ≥0.7 measured at 1122 
96 h p.i. before and after removing detached cells by changing the culture medium. The data 1123 
were generated from three independent experiments. Px, pixels. 1124 
 1125 
Fig. 7. Effects of RNA2.7 on viral spread. 1126 
Synchronized HF-Tet cells were infected at MOI=5 with UL36-GFP-WT, UL36-GFP-ΔRNA2.7 1127 
(denoted ΔRNA2.7) or UL36-GFP-ΔTATA (denoted ΔTATA). At 72–96 h p.i., infected cells were 1128 
used to seed plaques on sparse or confluent monolayers in the presence of anti-HCMV blocking 1129 
antibodies. GFP-expressing cells at 48 h p.i. were enumerated. Summary of results with Tukey 1130 
box-and-whisker plots representing three independent experiments in which all plaques were 1131 
assessed. 1132 
 1133 
Fig. 8. Effects of GRIM-19 on expression of regulated CMA genes. 1134 
HFT cells were transduced with lentivirus constructs expressing either a non-targeting shRNA as 1135 
negative control (-) or one of three separate GRIM-19-targeting shRNAs (KD1-KD3). Stable cell 1136 
lines established by puromycin selection were synchronized and mock-infected (mock) or 1137 
infected at MOI=5 with WT, ΔRNA2.7 or ΔTATA. (A) RT-PCR of CMA transcripts in RNA harvested 1138 
at 72 h p.i., using GAPDH as loading control. (B) Immunoblot of GRIM-19 levels in mock-infected 1139 













































Fig. 9. Effects of inhibiting viral DNA synthesis on cell movement. 1142 
Synchronized HF-Tet cells were infected at MOI=5 with UL36-GFP-WT, UL36-GFP-ΔRNA2.7 1143 
(denoted ΔRNA2.7) or UL36-GFP-ΔTATA (denoted ΔTATA), after which the UL36-GFP-WT-1144 
infected cells were treated immediately with PFA or left untreated. (A) Cell movement speed 1145 
measured by fluorescent live cell confocal microscopy and cell tracking at 48–96 h p.i., taking 1146 
images at 10 min intervals. The data represent three independent experiments, each with 1147 
duplicate wells and five independent fields of view per well. Significantly different results were 1148 
grouped using Tukey’s test (A, B and C), and error bars denote standard deviation values. (B) 1149 
RNA2.7 levels measured by RT-qPCR at 72 h p.i., with GAPDH serving as a loading control. Error 1150 
bars indicate standard deviation values between two independent experiments. 1151 
 1152 
Fig. 10. Effects of partially deleting RNA2.7 on expression of CMA genes and cell movement. 1153 
(A) Diagram depicting the regions deleted in the RNA2.7 mutants (Δ5’ and Δ3’) in comparison 1154 
with WT. The RNA2.7-coding region is indicated by a blue arrow, the TATA box by a red line, 1155 
and the polyadenylation (polyA) signal by a yellow line. The deleted regions are marked by grey-1156 
shaded rectangles. Numbers indicate the distance (nt) from the transcription initiation site (at 1 1157 
nt). (B) HFFF2 cells were infected at MOI=5 with WT, Δ5’, Δ3’, ΔRNA2.7 or ΔTATA and CMA 1158 
transcript levels in RNA harvested at 72 h p.i. were measured by RT-PCR, using GAPDH as 1159 
loading control. The data represent one of three independent experiments. RT, reverse 1160 
transcriptase. (C) HF-Tet cells were infected at MOI=5 with UL36-GFP-WT, UL36-GFP-Δ5’ 1161 
(denoted Δ5’), UL36-GFP-Δ3’ (denoted Δ3’), UL36-GFP-ΔRNA2.7 (denoted ΔRNA2.7) or UL36-1162 












































confocal microscopy and tracking analysis. For each experiment, ten random views of the field 1164 
were analysed per sample, resulting in the analysis of >1700 tracks after excluding low quality 1165 
tracks. Error bars denote standard deviation values. Significantly different results were grouped 1166 
using Tukey’s test (A, B and C). (D) Expression of the 5’ region and (E) the 3’ region of RNA2.7 1167 
determined by RT-qPCR, normalizing levels to GAPDH. In each panel, the data represent three 1168 
independent experiments, with error bars indicating standard deviation values.  1169 
 1170 
Fig 11. A+U content of mRNAs regulated in association with RNA2.7. 1171 
(A) The 99 upregulated CMA mRNAs. (B) All 785 upregulated mRNAs and all 146 downregulated 1172 
mRNAs.  1173 
 1174 
Fig. 12. Effects of inhibiting RNA synthesis on persistence of regulated CMA transcripts. 1175 
HFFF2 cells were infected at MOI=5 with WT, Δ5’, Δ3’, ΔRNA2.7 or ΔTATA, and then 12.5 μg/ml 1176 
actinomycin D (+) or solvent only (-) was added at 72 h p.i. At 120 h p.i., CMA transcript levels 1177 
were measured by RT-qPCR, normalizing levels to GAPDH: (A) STX3, (B) TPM3, (C) HEBP1 and 1178 
(D) DAG1. The NT level for each virus was then normalized to 1, and the level in actinomycin D-1179 
treated samples was calculated relative to the relevant NT sample. Error bars indicate standard 1180 
deviation values in four independent experiments. 1181 
 1182 













































HFFF2 cells were infected at MOI=5 with WT, ΔRNA2.7 or ΔTATA. Sequence reads generated 1185 
from polyadenylated RNA isolated at 72 h p.i. were aligned to individual viral CDSs or lncRNA 1186 
sequences and counted. Transcript expression in mutants compared to WT was determined as 1187 
log2 fold change (log2FC) values. Differential expression was plotted for (A) all sense transcripts 1188 
(except RNA2.7), (B) all antisense transcripts, (C) regulated sense transcripts only (q<0.05), and 1189 
(D) regulated antisense transcripts only (q<0.05). R and p define the strength and significance of 1190 
the correlation, respectively. 1191 
D
ow
nl
oa
de
d 
fr
om
 h
ttp
s:
//j
ou
rn
al
s.
as
m
.o
rg
/jo
ur
na
l/j
vi
 o
n 
05
 A
ug
us
t 2
02
1 
by
 2
.9
8.
19
2.
99
.
D
ow
nl
oa
de
d 
fr
om
 h
ttp
s:
//j
ou
rn
al
s.
as
m
.o
rg
/jo
ur
na
l/j
vi
 o
n 
05
 A
ug
us
t 2
02
1 
by
 2
.9
8.
19
2.
99
.
D
ow
nl
oa
de
d 
fr
om
 h
ttp
s:
//j
ou
rn
al
s.
as
m
.o
rg
/jo
ur
na
l/j
vi
 o
n 
05
 A
ug
us
t 2
02
1 
by
 2
.9
8.
19
2.
99
.
D
ow
nl
oa
de
d 
fr
om
 h
ttp
s:
//j
ou
rn
al
s.
as
m
.o
rg
/jo
ur
na
l/j
vi
 o
n 
05
 A
ug
us
t 2
02
1 
by
 2
.9
8.
19
2.
99
.
D
ow
nl
oa
de
d 
fr
om
 h
ttp
s:
//j
ou
rn
al
s.
as
m
.o
rg
/jo
ur
na
l/j
vi
 o
n 
05
 A
ug
us
t 2
02
1 
by
 2
.9
8.
19
2.
99
.
D
ow
nl
oa
de
d 
fr
om
 h
ttp
s:
//j
ou
rn
al
s.
as
m
.o
rg
/jo
ur
na
l/j
vi
 o
n 
05
 A
ug
us
t 2
02
1 
by
 2
.9
8.
19
2.
99
.
D
ow
nl
oa
de
d 
fr
om
 h
ttp
s:
//j
ou
rn
al
s.
as
m
.o
rg
/jo
ur
na
l/j
vi
 o
n 
05
 A
ug
us
t 2
02
1 
by
 2
.9
8.
19
2.
99
.
D
ow
nl
oa
de
d 
fr
om
 h
ttp
s:
//j
ou
rn
al
s.
as
m
.o
rg
/jo
ur
na
l/j
vi
 o
n 
05
 A
ug
us
t 2
02
1 
by
 2
.9
8.
19
2.
99
.
D
ow
nl
oa
de
d 
fr
om
 h
ttp
s:
//j
ou
rn
al
s.
as
m
.o
rg
/jo
ur
na
l/j
vi
 o
n 
05
 A
ug
us
t 2
02
1 
by
 2
.9
8.
19
2.
99
.
D
ow
nl
oa
de
d 
fr
om
 h
ttp
s:
//j
ou
rn
al
s.
as
m
.o
rg
/jo
ur
na
l/j
vi
 o
n 
05
 A
ug
us
t 2
02
1 
by
 2
.9
8.
19
2.
99
.
D
ow
nl
oa
de
d 
fr
om
 h
ttp
s:
//j
ou
rn
al
s.
as
m
.o
rg
/jo
ur
na
l/j
vi
 o
n 
05
 A
ug
us
t 2
02
1 
by
 2
.9
8.
19
2.
99
.
D
ow
nl
oa
de
d 
fr
om
 h
ttp
s:
//j
ou
rn
al
s.
as
m
.o
rg
/jo
ur
na
l/j
vi
 o
n 
05
 A
ug
us
t 2
02
1 
by
 2
.9
8.
19
2.
99
.
D
ow
nl
oa
de
d 
fr
om
 h
ttp
s:
//j
ou
rn
al
s.
as
m
.o
rg
/jo
ur
na
l/j
vi
 o
n 
05
 A
ug
us
t 2
02
1 
by
 2
.9
8.
19
2.
99
.
D
ow
nl
oa
de
d 
fr
om
 h
ttp
s:
//j
ou
rn
al
s.
as
m
.o
rg
/jo
ur
na
l/j
vi
 o
n 
05
 A
ug
us
t 2
02
1 
by
 2
.9
8.
19
2.
99
.
